Issue 220
Digital health research from Brian Dolan

 E&O: Software as a Medical Device

Welcome back to E&O: SaMD, a paying subscribers-only weekly newsletter focused on the world of digital pharma products, prescription digital therapeutics and other FDA-regulated digital health.

Here's a quick rundown of things happening in FDA-regulated and pharma-focused digital health:

• MedRhythms, developers of InTandem, an FDA-authorized, Rx-only